Biocon Limited
NSE: BIOCON | Information Technology
Market Fundamentals
Stock Intelligence & News
Biocon Ltd (532523)
Company Statement
Read Full Analysis →Biocon Limited
Biocon Limited has informed the Exchange regarding 'Company Statement'. |SUBJECT: Updates
Read Full Analysis →Biocon Shares Surge Nearly 3% After Q1 Profit Jumps 350%
Biocon has been steadily gaining over three years.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Biocon Q1 FY27 slides: profit surges 245% on biosimilar strength
Biocon Q1 FY27 slides: profit surges 245% on biosimilar strength
Read Full Analysis →Earnings call transcript: Biocon Q1 2026 profit gains lift shares 1.9%
Earnings call transcript: Biocon Q1 2026 profit gains lift shares 1.9%
Read Full Analysis →Biocon Q1 Results: Profit Spikes 350%, Revenue Exceeds Rs 4,300 Crore
Biocon Ltd. reported a 348.4% year-on-year jump in consolidated net profit to Rs 141 crore for the quarter ended June 2026, compared with Rs 31.4 crore in the year-ago period.
Read Full Analysis →Biocon Limited
Biocon Limited has informed the Exchange regarding a press release dated July 09, 2026, titled " Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili , a Biosimilar to Eylea® (Aflibercept) ". |SUBJECT: Press Release
Read Full Analysis →Biocon stock ticks up as Yesafili Biosimilar clinical data gets published in peer-reviewed journals
CEO Shreehas Tambe called the publications an important milestone for the company’s aflibercept biosimilar programme
Read Full Analysis →Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM Financial
JM Financial anticipates significant shifts in the MSCI India Standard Index. Laurus Labs and Biocon are flagged as high-probability additions from the Small Cap Index, while Ather Energy and SAIL are medium-probability candidates. SBI Card faces a high probability of exclusion. These potential changes could lead to substantial passive fund inflows into India, estimated around $3.2 billion, impacting institutional investors.
Read Full Analysis →August MSCI Rejig Could Trigger Over Rs 30,000 Crore Inflows Into India; Laurus Labs, Biocon Lead Race
Among the likely beneficiaries, Laurus Labs and Biocon have been assigned a high probability of moving from the MSCI India Small Cap Index to the MSCI India Standard Index.
Read Full Analysis →Get instant alerts when BIOCON breaks news
Join investors who track Biocon Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BIOCON?
BIOCON is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Biocon Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BIOCON to your custom watchlist.